Navigation Links
CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010
Date:9/16/2010

WASHINGTON, Sept. 16 /PRNewswire/ -- CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010.  The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".

Some of the highlights of the presentation will include an exploration of the clinical benefits of CID's Abluminal Reservoir Technology (ART) and drug delivery technology. By surrounding molecules of drug with amphiphilic carriers and embedding them into reservoirs on the stent's outer surface, CID drug-eluting stents are able to deliver drug to the coronary arteries without using any polymers, which can cause serious complications in patients.

CID's unique ART system with its amphiphilic carrier is more physiological and patients who receive these stents are less likely to have inflammation and thrombosis within their coronary arteries. Moreover CID DES technology features an integral Bio-Inducer Surface (BIS) which implies less medication to prevent blood clotting after the stent has been deployed for enhanced safety.

Commenting on the innovative technology in its new Cre8 DES, Franco Vallana, Chief Executive Officer of CID s.r.l. said, "We have always known that the more the stent and the drug delivery system are designed and developed to harmonize with the human body, the better the short- and long-term results will be. Combining ART with our innovative drug formulation with amphiphilic carrier into a completely polymer-free stent will allow doctors to provide their patients with stents that are more physiological and complement the body's natural systems."


'/>"/>
SOURCE CID s.r.l.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vista Partners Updates Coverage on Raptor Pharmaceutical Corp.
2. Encorium Group, Inc. Provides Update on Its Previously Announced Rights Offering
3. Shire Update on ProAmatine(R) (midodrine HCl)
4. Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Cobalis Corp. Provides Marketing Update Conference Call for Investors
7. China Sky One Medical Updates Financial Guidance for 2010
8. Halozyme Provides HYLENEX® Product Reintroduction Update
9. Personalized Medicine: Conference Provides Update on Progress and Prospects
10. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
11. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished ... the Outlier Leadership Series, Outliers in Writing, set to publish in summer 2017. ... Medicine at the University of Arizona College of Medicine. He also serves as Medical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):